Furosemide
FUROSEMIDE TABLETS, USP 20, 40, and 80 mg
Approved
Approval ID
6be1addd-a811-47fc-8650-6870d661c234
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 30, 2021
Manufacturers
FDA
Major Pharmaceuticals
DUNS: 191427277
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
furosemide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0904-7178
Application NumberANDA076796
Product Classification
M
Marketing Category
C73584
G
Generic Name
furosemide
Product Specifications
Route of AdministrationORAL
Effective DateDecember 30, 2021
FDA Product Classification
INGREDIENTS (5)
FUROSEMIDEActive
Quantity: 40 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
furosemide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0904-7177
Application NumberANDA076796
Product Classification
M
Marketing Category
C73584
G
Generic Name
furosemide
Product Specifications
Route of AdministrationORAL
Effective DateDecember 30, 2021
FDA Product Classification
INGREDIENTS (5)
FUROSEMIDEActive
Quantity: 20 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT